Psilocybin Therapeutic Research: The Present and Future Paradigm

Psilocybin, the active component in magic mushrooms, may offer therapeutic benefits for conditions like major depressive disorder and addiction without the addictiveness or overdose risk of drugs such as cocaine, heroin, alcohol, and methamphetamine. The need for new treatments is urgent due to rising rates of addiction, overdose, and suicide in the United States and worldwide. Anecdotal and contemporary pharmacological reports suggest psilocybin's potential for treating mental health disorders. This Viewpoint summarizes current psilocybin therapeutic research and offers insights into future directions for scientific focus.

Study at a glance

Abstract

Psilocybin, an active component in "magic mushroom", may have the potential to meet the therapeutic needs for a number of indications without the addictiveness and overdose risk of other mind-altering drugs, such as cocaine, heroin, alcohol, methamphetamine, and so forth. The need for new therapies is urgent because addiction, overdose, and suicide deaths have risen throughout the United States and around the world. Anecdotal and contemporary pharmacological reports have provided some indication about the therapeutic use of psilocybin for the treatment of mental health disorders such as major depressive disorder and addiction disorders. In this Viewpoint, I summarize the current state of psilocybin therapeutic research and attempt to provide some insight into future directions on which the scientific community may wish to focus.